Furthermore, mutational signatures associated with APOBEC (Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit) activity have been shown to influence the tumor’s immune microenvironment and its response to immune therapies. This evidence concerns the gene APOB and neoplasm.